Non Small Cell Lung Cancer Thumbnail

JMCP Outsert - Precision Oncology in NSCLC (Biomarker)

The lack of implementation of predictive biomarkers in clinical practice results in a significant number of individuals with NSCLC not deriving benefits from targeted treatments. Payers have the potential to shape various aspects of the precision oncology pathway, such as addressing biomarker test ordering, utilizing test results to inform treatment decisions, implementing quality measurements, and understanding cost-effectiveness.
Precision Medicine
AMCP Podcast Series Featured Episode

AMCP Format for Formulary Submissions v4.1 Revisions: Public Comment Period

Don't miss out on your chance to comment! Health care expert Fred Goldstein sits down with Ellen Whipple, BS Pharm, PharmD, to discuss the AMCP Format revision focused on digital therapeutics, health disparities, real-world evidence, PIE Deck guidance, and streamlining dossier development.
AMCP Podcast Series Featured Episode

Capitol Hill PBM Reforms

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent action on Capitol Hill surrounding pharmacy benefit manager reform.
Practically speaking, does biosimilar interchangeability matter today

AMCP Volunteer Spotlight: Matt Moen

AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Matt Moen, PharmD, MBA, AMCP Membership Committee member.   
AMCP Membership